Kivonat:
Myocardial infarction and resulting heart failure remain the leading causes of death worldwide. Therefore, novel therapies are required to protect the heart against the detrimental effects of acute ischemia/reperfusion injury. Micro-RNAs are promising novel targets for cardioprotection as highlighted by recent seminal position papers and reviews (Hausenloy et al., 2017; Varga et al., 2015; Perrino et al., 2017 [1-3]).